This month we’re exploring the data that we generate through CiteAb, which means we are releasing new market reports every week, throughout the whole of September!
Today we are looking at trends in antibody citation data for the top 1000 most cited protein targets antibodies are raised against, allowing suppliers to ensure they are stocking products that cover the most used or fastest rising targets.
The CiteAb Protein Target Trends market report provides a unique view of which antibody targets are most frequently used by researchers. We generated the data by combining all the citations for antibodies which were raised against the same target protein, allowing us to provide a unique view of how often each protein target is cited and how this citation rate is changing over time.
Speaking about the data, Dr Andrew Chalmers, founder of CiteAb, said: “Unsurprisingly, 950 out of the top 1000 proteins antibodies are raised against are human proteins, with a small number of proteins from other species appearing, including mouse and rat.
“We can also see that over half of all our antibody citations are against just 120 protein targets, however there is also a long tail of many more with a far smaller number of citations.”
The top protein targets in today’s market report are dominated by cytoskeletal proteins, histones, signaling molecules (e.g. AKT) and proteins used as loading controls such as GAPDH.
The top three proteins antibodies are raised against are:
- ACTB_HUMAN (Actin, cytoplasmic 1)
- H31T_HUMAN (Histone H3.1t)
- AKT1_HUMAN (RAC-alpha serine/threonine-protein kinase).
This report, like all our reports, is based on the analysis of hundreds of thousands of antibody citations.